When the group of 17 C9 + ALS and ALS-FTD patients were compared to the group of 22 sALS patients, C9 + ALS patients had thinner cortex in many areas, particularly in frontal and temporal regions (Fig. 2 B). The gene discussed is C9; the disease is frontotemporal dementia.